# Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.

> **NCT07352878** · — · NOT_YET_RECRUITING · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 150 (estimated)

## Conditions studied

- Thalassemia
- Iron Overload

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07352878
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07352878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07352878, "Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07352878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*